PRL and polycystic ovary syndrome: In the PCOS group, significant reductions were observed in DHEA-S (from 407.5 (247.5–534.2) to 301.0 (210.7–405.7) μg/dL, p < 0.001), total testosterone (from 0.65 (0.54–0.85) to 0.49 (0.32–0.58) ng/mL, p < 0.001) (Fig. 1), and PRL levels (from 40.0 (28.2–61.5) to 1.1 (0.4–11.2) ng/mL, p < 0.001) following treatment.